Cytotoxic T lymphocytes (CTLs) and NK cells are essential elements in the defense against tumor development and represent promising candidates for cancer immunotherapy through two major pathways: granzymes and the TNF superfamily 46-48. The gene discussed is TNF; the disease is cancer.